Works by Ghanavat, Majid


Results: 14
    1
    2
    3
    4

    A randomized, two-armed, double-blind, single-dose, cross-over, bioequivalence clinical trial to compare pharmacokinetic parameters and safety of recombinant human factor VIII with Fc fusion produced by AryoGen Pharmed Company versus Elocta<sup>®</sup> (reference product) in previously treated patients with severe haemophilia A

    Published in:
    Annals of Hematology, 2025, v. 104, n. 2, p. 1195, doi. 10.1007/s00277-025-06242-z
    By:
    • Eghbali, Aziz;
    • Eshghi, Peyman;
    • Toogeh, Gholamreza;
    • Alavi, Samin;
    • Badiei, Zahra;
    • Ghanavat, Majid;
    • Bordbar, Mohammadreza;
    • Bazrafshan, Asghar;
    • Karimi, Katayoon;
    • Ahmadinejad, Minoo;
    • Sabzvari, Araz;
    • Kafi, Hamidreza
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14